AmerisourceBergen Corporation (Holding Co) (ABC) Insider Peyton R. Howell Sells 3,000 Shares
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) insider Peyton R. Howell sold 3,000 shares of the firm’s stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $86.20, for a total transaction of $258,600.00. Following the sale, the insider now directly owns 49,189 shares of the company’s stock, valued at $4,240,091.80. The transaction was disclosed in a document filed with the SEC, which is available at this link.
AmerisourceBergen Corporation (ABC) traded down $0.06 during midday trading on Thursday, reaching $85.93. 1,763,704 shares of the company’s stock were exchanged, compared to its average volume of 1,796,555. AmerisourceBergen Corporation has a 12-month low of $71.90 and a 12-month high of $97.85. The company has a quick ratio of 0.48, a current ratio of 0.91 and a debt-to-equity ratio of 1.83. The company has a market cap of $18,731.06, a P/E ratio of 14.58, a price-to-earnings-growth ratio of 1.49 and a beta of 1.00.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. The firm had revenue of $39.12 billion for the quarter, compared to the consensus estimate of $40.10 billion. During the same period in the prior year, the firm posted $1.30 EPS. The firm’s revenue was up 4.2% compared to the same quarter last year. research analysts predict that AmerisourceBergen Corporation will post 6.07 EPS for the current fiscal year.
Several institutional investors have recently bought and sold shares of ABC. Parallel Advisors LLC lifted its position in shares of AmerisourceBergen by 3.2% in the 2nd quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock worth $104,000 after buying an additional 34 shares during the last quarter. Sun Life Financial INC lifted its position in shares of AmerisourceBergen by 15,000.0% in the 2nd quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock worth $114,000 after buying an additional 1,200 shares during the last quarter. D.A. Davidson & CO. lifted its position in shares of AmerisourceBergen by 29.0% in the 2nd quarter. D.A. Davidson & CO. now owns 1,668 shares of the company’s stock worth $157,000 after buying an additional 375 shares during the last quarter. Intl Fcstone Inc. bought a new position in shares of AmerisourceBergen in the 2nd quarter worth about $201,000. Finally, Pinnacle Associates Ltd. bought a new position in shares of AmerisourceBergen in the 2nd quarter worth about $203,000. Institutional investors own 67.83% of the company’s stock.
A number of equities research analysts recently weighed in on the stock. Cowen raised shares of AmerisourceBergen from a “market perform” rating to an “outperform” rating in a report on Tuesday, October 10th. Jefferies Group set a $85.00 price objective on shares of AmerisourceBergen and gave the company a “hold” rating in a research note on Sunday, October 29th. Zacks Investment Research downgraded shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. Robert W. Baird set a $99.00 price objective on shares of AmerisourceBergen and gave the company a “buy” rating in a research note on Friday, December 1st. Finally, Morgan Stanley downgraded shares of AmerisourceBergen from an “overweight” rating to an “equal weight” rating in a research note on Thursday, September 14th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. AmerisourceBergen has a consensus rating of “Buy” and an average target price of $91.95.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with MarketBeat.com's FREE daily email newsletter.